<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02139891</url>
  </required_header>
  <id_info>
    <org_study_id>PTVCARDIO022014</org_study_id>
    <nct_id>NCT02139891</nct_id>
  </id_info>
  <brief_title>Effects of Multipoint Pacing CRT-D on Neurohormonal Activation.</brief_title>
  <official_title>Randomized, Crossover Study of the Effects of MultiPoint Left Ventricular Pacing on Neurohormonal Activation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rome Tor Vergata</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rome Tor Vergata</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine the additional clinical benefit conferred by multipoint pacing (MPP)
      compared to standard CRT over a period of 3 months. Patients will be randomized to MPP ON vs.
      OFF and followed for a total of 6 months. This includes two crossover periods for each pacing
      modality (MPP on vs. off).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiac resynchronization therapy (CRT) is limited by a high proportion of non-responders.
      Pacing activation from multiple separated left ventricular (LV) sites might improve the
      depolarization pattern, thereby promoting more physiological activation. To explore the
      effect of MPP on cardiac neuro-hormonal activity, the investigators will enroll approximately
      30 patients who already underwent CRT-D implantation with a quadripolar LV lead connected to
      a device capable of MPP.

      This pilot study will have a randomized, double-blind, cross-over design. Patients will be
      randomized to receive either standard biventricular pacing (MPP-OFF) or MPP (MPP-ON) within
      4-6 months following the implantation procedure. Each subject will crossover to the other
      study group after three months. The baseline evaluation should be acquired prior to the
      device being programmed to the randomized setting. Repeat evaluations will be performed at
      the end of each 3 month crossover period.

      Participation in this study will last approximately 6 months. Patients, as well as
      investigators other than the EP physicians, will be blinded to the pacing mode.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in blood concentrations of N-terminal pro-B type natriuretic peptide (NT pro-BNP)</measure>
    <time_frame>Baseline. 3-Month. 6-Month.</time_frame>
    <description>Changes in plasma NT pro-BNP using the difference from baseline to three months as compared to the difference from three to six months within a patient.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in Neurohormonal Activation</measure>
    <time_frame>Baseline. 3-Month. 6-Month.</time_frame>
    <description>Renin, Aldosteron, Norepinephrine, Endothelin-1.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Failure Hospitalizations</measure>
    <time_frame>3-Month. 6-Month.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New York Heart Association (NYHA) Class changes</measure>
    <time_frame>Baseline. 3-Month. 6-Month.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Quality of Life (QOL), as assessed by the Minnesota Living With Heart Failure Questionnaire</measure>
    <time_frame>Baseline. 3-Month. 6-Month.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic changes</measure>
    <time_frame>Baseline. 3-Month. 6-Month.</time_frame>
    <description>Left ventricular end diastolic volume. Left ventricular end systolic volume. Left ventricular ejection fraction. Mitral regurgitation severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Appropriate device interventions (anti-tachycardia pacing or shock)</measure>
    <time_frame>3-Month. 6-Month.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phrenic Nerve Complication Free Rate</measure>
    <time_frame>3-Month. 6-Month.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of atrial and ventricular arrhythmias (amount and duration [h/day]).</measure>
    <time_frame>3-Month. 6-Month.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flow-mediated vasodilation</measure>
    <time_frame>Baseline. 3-month. 6-month</time_frame>
    <description>Differences in FMD between groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Packer's clinical composite score</measure>
    <time_frame>Baseline. 3-month. 6-month.</time_frame>
    <description>Distribution of &quot;improved&quot;, &quot;unchanged&quot; and &quot;worsened&quot; patients as defined per Packer's clinical composite score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6-Minute-Walking-Distance</measure>
    <time_frame>Baseline. 3 Month. 6 Month.</time_frame>
    <description>The distance walked by subjects during a 6 minutes walking test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>MultiPoint Pacing &quot;On&quot;</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be randomized to the MPP-ON Arm vs MPP-OFF in in crossover fashion with 3 months in each period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MultiPoint Pacing &quot;Off&quot;</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be randomized to the MPP-OFF arm vs MPP-ON in crossover fashion with 3 months in each period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardiac Resynchronization Therapy with MultiPoint Pacing</intervention_name>
    <arm_group_label>MultiPoint Pacing &quot;On&quot;</arm_group_label>
    <arm_group_label>MultiPoint Pacing &quot;Off&quot;</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients implanted with a St. Jude Medical CRT-D system with MPP capability

          -  Patients must be willing and able to sign an appropriate informed consent form and
             comply with study requirements

          -  NT pro-BNP levels equal to or greater than 500 pg/ml.

        Exclusion Criteria:

          -  History of stroke, PCI, myocardial infarction or unstable angina pectoris within the
             last 3 months.

          -  Atrial fibrillation with noncontrolled heart rate

          -  Need for intravenous inotropic support for CHF

          -  Classification of Status 1 for cardiac transplantation or consideration for
             transplantation over the next 12 months

          -  Undergone a cardiac transplantation

          -  Currently participating in any other clinical investigation

          -  Life expectancy &lt; 12 months due to a disorder other than CHF

          -  Inability to comply with the follow-up procedures

          -  Patients who are or may potentially be pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giovanni B Forleo, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rome Tor Vergata</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Istituto Clinico St. Ambrogio</name>
      <address>
        <city>Milano</city>
        <zip>20149</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico Tor Vergata</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Pappone C, Ćalović Ž, Vicedomini G, Cuko A, McSpadden LC, Ryu K, Romano E, Saviano M, Baldi M, Pappone A, Ciaccio C, Giannelli L, Ionescu B, Petretta A, Vitale R, Fundaliotis A, Tavazzi L, Santinelli V. Multipoint left ventricular pacing improves acute hemodynamic response assessed with pressure-volume loops in cardiac resynchronization therapy patients. Heart Rhythm. 2014 Mar;11(3):394-401. doi: 10.1016/j.hrthm.2013.11.023. Epub 2013 Nov 28.</citation>
    <PMID>24291411</PMID>
  </reference>
  <reference>
    <citation>Rinaldi CA, Leclercq C, Kranig W, Kacet S, Betts T, Bordachar P, Gutleben KJ, Shetty A, Donal E, Keel A, Ryu K, Farazi TG, Simon M, Naqvi TZ. Improvement in acute contractility and hemodynamics with multipoint pacing via a left ventricular quadripolar pacing lead. J Interv Card Electrophysiol. 2014 Jun;40(1):75-80. doi: 10.1007/s10840-014-9891-1. Epub 2014 Mar 14.</citation>
    <PMID>24626999</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 12, 2014</study_first_submitted>
  <study_first_submitted_qc>May 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2014</study_first_posted>
  <last_update_submitted>September 25, 2017</last_update_submitted>
  <last_update_submitted_qc>September 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rome Tor Vergata</investigator_affiliation>
    <investigator_full_name>Giovanni B Forleo</investigator_full_name>
    <investigator_title>MD, PhD.</investigator_title>
  </responsible_party>
  <keyword>Cardiac Resynchronization Therapy</keyword>
  <keyword>non responders</keyword>
  <keyword>MultiPoint Pacing (MPP)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

